3 case studies on how to characterize challenging drug discovery targets — membrane proteins, peptide libraries, and PROTACs December 18, 2020 A caveat to a successful pharmaceutical industry in which many effective drugs have already been… Dianthus
The NanoTemper Story – Chapter 5: The Dianthus August 25, 2020 Almost as soon as the Monolith launched, the handful of people that made up NanoTemper… Dianthus Products
3 big takeaways from SLAS on the future of automation and screening February 11, 2020 5,200 researchers, representing all of life sciences, gathered in San Diego in late January to… Dianthus
When aptamers are the better choice over mAbs February 7, 2020 Monoclonal antibodies (mAbs) have become the molecule of choice when highly specific molecular recognition is… Dianthus Monolith
6 ingredients for a successful fragment library January 17, 2020 Fragment-based drug discovery (FBDD) has become a major strategy to derive novel lead candidates in… Dianthus
PROTACs: the game-changing technology that promises to tackle “undruggable” proteins November 7, 2019 Almost all pharmaceutical drugs today act by binding to disease-causing proteins and inhibiting their activity.… Dianthus
5 things you must do while in Liverpool for ELRIG Drug Discovery October 31, 2019 Here’s how to make your trip unforgettable. 1. Immerse yourself in Liverpool’s… Dianthus
5 things you must do in Barcelona while at SLAS Europe (according to a local) June 17, 2019 Here’s how to make your trip memorable. 1. Be awe-inspired at La… Dianthus
Great things start small and so does the discovery of drug candidates May 28, 2019 The famous painter Vincent Van Gogh once said, “Great things are done by a series… Dianthus